Increased concentrations of Aβ in the cerebrospinal fluid (CSF) and Aβ deposition in the brain are observed before the onset of other AD symptoms; these changes are followed by hippocampal atrophy, increased concentrations of tau in the CSF, and ultimately, cognitive impairment3,4. This evidence concerns the gene MAPT and Alzheimer disease.